Different Chemotherapy Regimens and Pathologic Complete Response in Triple-Negative Breast Cancer: An Updated Network Meta-Analysis of Phase 3 Trials
Article in Medicina (February 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Addition of PD-1/PD-L1 inhibitors to chemotherapy for triple-negative breast cancer: a meta-analysis
Article in Frontiers in Oncology (February 2024)
From Reductionistic Approach to Systems Immunology Approach for the Understanding of Tumor Microenvironment
Article in International Journal of Molecular Sciences (July 2023)